趋势研判!2026年中国放疗定位产品行业政策、产业链、市场规模、竞争格局及发展趋势分析:癌症发病率增加及放射治疗应用率提升推动市场规模快速扩大[图]
Chan Ye Xin Xi Wang·2026-01-04 01:23

Core Viewpoint - The demand for radiotherapy positioning products in China is expected to double due to the increasing cancer population and advancements in radiotherapy technology, leading to significant market growth from 167 million yuan in 2019 to 346 million yuan by 2025, and projected to reach 411 million yuan by 2026 [1][4]. Industry Definition and Classification - Radiotherapy positioning products are essential for ensuring precise patient positioning during treatment, which is critical for targeting tumors accurately while minimizing damage to surrounding tissues [2][3]. - Key products include patient positioning bags, positioning films, and intelligent positioning systems, with positioning films being the most widely used [3]. Industry Development Status - Cancer is a major health threat, and radiotherapy is one of the three primary treatment methods, applicable in nearly all cancer treatments [3]. - The global market for radiotherapy positioning films is projected to grow from 273 million USD in 2019 to 403 million USD by 2025, with expectations of reaching 435 million USD by 2026 [4]. Industry Chain - The upstream of the industry includes raw materials such as polycaprolactone and polyurethane, while the downstream primarily consists of hospitals and radiotherapy centers, with hospitals accounting for approximately 75% of the market [4]. Policy Environment - Recent supportive policies in China, such as the "14th Five-Year" plan for large medical equipment and reforms in high-value medical consumables, are significant drivers for the development of the radiotherapy positioning products industry [6]. Competitive Landscape - The market is dominated by key players such as CIVCO Radiotherapy, Guangzhou Kelaidi Medical Equipment Co., Ltd., and Elekta, with a high concentration of industry leaders [8]. - Guangzhou Kelaidi holds a substantial market share in China, with its positioning products generating 2.23 billion yuan in revenue, accounting for 78.28% of its total revenue in 2024 [8][9]. Industry Development Trends - The industry is moving towards higher precision, intelligence, safety, and comfort in products, driven by the demand for reliable and accurate positioning in the era of "precision radiotherapy" [9].

趋势研判!2026年中国放疗定位产品行业政策、产业链、市场规模、竞争格局及发展趋势分析:癌症发病率增加及放射治疗应用率提升推动市场规模快速扩大[图] - Reportify